Comments
Loading...

Aurinia Pharmaceuticals

AUPHNASDAQ
Logo brought to you by Benzinga Data
$5.68
00.00%
At Close: -
$5.68
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Q2 2024 Earnings in 3 days from now on Thu Aug 1st, before the market open
Conference call scheduled in 3 days at 8:30 AM Click to view the webcast

Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Get Alert
01/05/2024AUPH
Aurinia Pharmaceuticals
FY2023$176.00M$176.00M$174.71MGet Alert
01/05/2024AUPH
Aurinia Pharmaceuticals
Q42023$45.00M$45.00M$44.20MGet Alert
11/02/2023AUPH
Aurinia Pharmaceuticals
FY2023$155.00M$160.00M$161.65MGet Alert
08/03/2023AUPH
Aurinia Pharmaceuticals
FY2023$150.00M$160.00M$154.35MGet Alert
05/04/2023AUPH
Aurinia Pharmaceuticals
FY2023$135.00M$155.00M$142.68MGet Alert
01/06/2023AUPH
Aurinia Pharmaceuticals
FY2022$134.00M$134.00M$132.68MGet Alert
01/06/2023AUPH
Aurinia Pharmaceuticals
Q42022$28.40M$28.40M$26.97MGet Alert

FAQ

Q

What is the most recent guidance for Aurinia Pharmaceuticals (AUPH)?

A

There have been no specific sales or earnings guidance reported for Aurinia Pharmaceuticals in recent months.

Browse guidance and forecast on all stocks.